Fluticasone inhaler
Pro Research Analysisby 
Searched over 200M research papers for "fluticasone inhaler"
Efficacy and Safety of Fluticasone Inhalers in Asthma Management
Introduction to Fluticasone Inhalers
Fluticasone propionate is a widely used inhaled corticosteroid (ICS) for managing asthma. It is known for its potent anti-inflammatory properties and is often combined with other medications like salmeterol to enhance therapeutic outcomes. This article synthesizes research findings on the efficacy and safety of fluticasone inhalers, focusing on various formulations and delivery devices.
Fluticasone Propionate in Pediatric Asthma
Efficacy in Children
Fluticasone propionate has been shown to significantly improve lung function in children with persistent asthma. A study involving 437 children aged 4 to 11 years demonstrated that fluticasone propionate administered via Diskus or Diskhaler inhalers significantly improved forced expiratory volume in one second (FEV1), peak expiratory flow (PEF), and asthma symptom scores. Additionally, it reduced the need for rescue medication and nighttime awakenings.
Safety Profile
The same study reported that fluticasone propionate did not suppress morning plasma cortisol concentrations or affect 24-hour urinary free-cortisol excretion, indicating a favorable safety profile. Adverse events were primarily mild and related to the pharmacologic effects of inhaled corticosteroids.
Combination Therapy with Salmeterol
Efficacy in Steroid-Dependent Asthma
Combining fluticasone propionate with salmeterol in a single inhaler (Seretide) has been found to be as effective as administering the two drugs separately. A study involving 503 patients with steroid-dependent asthma showed that the combination therapy significantly improved morning PEF and other lung function measures compared to fluticasone alone. Both combination and concurrent therapies were superior to corticosteroid monotherapy.
Dose Reduction and Asthma Control
A phase IV clinical study compared a new formulation of fluticasone/salmeterol in a metered-dose inhaler (MDI HFA) with a dry-powder inhaler (DPI). The study found that the MDI HFA formulation allowed for a reduction in the daily dose of corticosteroid while providing optimal asthma control. Both formulations showed comparable improvements in lung function and asthma symptoms, with the MDI HFA group experiencing fewer incidences of hoarseness.
Device Usability and Function
Generic Inhalers
A generic combination of fluticasone propionate and salmeterol in a premetered, multidose, nonreusable inhaler was evaluated for usability, function, and robustness. The device was found to be user-friendly and effective in delivering the medication, even to patients with severe respiratory disease. The study confirmed that the generic device met all key quality parameters and showed no evidence of chemical degradation or microbial contamination.
Diskus and Diskhaler Devices
Fluticasone propionate administered via Diskus and Diskhaler devices has been shown to be effective in improving lung function and reducing asthma symptoms in patients with mild-to-moderate asthma. Both devices demonstrated similar efficacy and safety profiles, with significant improvements in FEV1, PEF, and asthma symptom scores.
Long-Term Efficacy and Safety
Once-Daily vs. Twice-Daily Regimens
A long-term study evaluated the efficacy and safety of fluticasone propionate administered once or twice daily over a year. Both regimens significantly improved lung function and asthma control, with twice-daily dosing showing greater improvements in some parameters during the initial 12 weeks. The treatment was well tolerated over the 54-week period, with few drug-related adverse events.
Conclusion
Fluticasone propionate, whether used alone or in combination with salmeterol, is effective and safe for managing asthma across different age groups and severity levels. Various delivery devices, including Diskus, Diskhaler, and MDI HFA, have been shown to be effective in delivering the medication. Long-term use of fluticasone propionate is well tolerated, making it a reliable option for asthma management.
Sources and full results
Most relevant research papers on this topic